Your session is about to expire
← Back to Search
Corticosteroid
Methylprednisolone (MPA) for Shoulder Pain
Phase 4
Waitlist Available
Led By Tyler Brolin, MD
Research Sponsored by Campbell Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-injection day 1 through 7
Awards & highlights
Study Summary
This trial compares the FLARE reaction rates to shoulder injections.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-injection day 1 through 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-injection day 1 through 7
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of a Flare Reaction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: methylprednisolone acetate (MPA)Experimental Treatment1 Intervention
subacromial or glenohumeral shoulder injection
Group II: triamcinolone acetonide (TA)Active Control1 Intervention
subacromial or glenohumeral shoulder injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methylprednisolone
FDA approved
Find a Location
Who is running the clinical trial?
Campbell ClinicLead Sponsor
10 Previous Clinical Trials
1,401 Total Patients Enrolled
Tyler Brolin, MDPrincipal InvestigatorCampbell Clinic
1 Previous Clinical Trials
82 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger